User menu

[Insulin Pump Therapy: Guidelines for Successful Outcomes]

Bibliographic reference Hermans, Michel. [Insulin Pump Therapy: Guidelines for Successful Outcomes].In: Diabetes & Metabolism, Vol. 35, p. A29-A29 (2009)
Permanent URL http://hdl.handle.net/2078.1/58989
  1. Diabetes mellitus (2008)
  2. Alexander G. Caleb, Sehgal Niraj L., Moloney Rachael M., Stafford Randall S., National Trends in Treatment of Type 2 Diabetes Mellitus, 1994-2007, 10.1001/archinte.168.19.2088
  3. Jakisch B. I., Wagner V. M., Heidtmann B., Lepler R., Holterhus P-M., Kapellen T. M., Vogel C., Rosenbauer J., Holl R. W., , Comparison of continuous subcutaneous insulin infusion (CSII) and multiple daily injections (MDI) in paediatric Type 1 diabetes: a multicentre matched-pair cohort analysis over 3 years : Original article, 10.1111/j.1464-5491.2007.02311.x
  4. Hoogma R. P. L. M., Hammond P. J., Gomis R., Kerr D., Bruttomesso D., Bouter K. P., Wiefels K. J., de la Calle H., Schweitzer D. H., Pfohl M., Torlone E., Krinelke L. G., Bolli G. B., , Comparison of the effects of continuous subcutaneous insulin infusion (CSII) and NPH-based multiple daily insulin injections (MDI) on glycaemic control and quality of life: results of the 5-nations trial, 10.1111/j.1464-5491.2005.01738.x
  5. Doyle E. A., Weinzimer S. A., Steffen A. T., Ahern J. A. H., Vincent M., Tamborlane W. V., A Randomized, Prospective Trial Comparing the Efficacy of Continuous Subcutaneous Insulin Infusion With Multiple Daily Injections Using Insulin Glargine, 10.2337/diacare.27.7.1554
  6. Hirsch I. B., Bode B. W., Garg S., Lane W. S., Sussman A., Hu P., Santiago O. M., Kolaczynski J. W., , Continuous Subcutaneous Insulin Infusion (CSII) of Insulin Aspart Versus Multiple Daily Injection of Insulin Aspart/Insulin Glargine in Type 1 Diabetic Patients Previously Treated With CSII, 10.2337/diacare.28.3.533
  7. Raskin P., Bode B. W., Marks J. B., Hirsch I. B., Weinstein R. L., McGill J. B., Peterson G. E., Mudaliar S. R., Reinhardt R. R., Continuous Subcutaneous Insulin Infusion and Multiple Daily Injection Therapy Are Equally Effective in Type 2 Diabetes: A randomized, parallel-group, 24-week study, 10.2337/diacare.26.9.2598
  8. , Implementation of Treatment Protocols in the Diabetes Control and Complications Trial, 10.2337/diacare.18.3.361
  9. The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus, 10.1056/nejm199309303291401
  10. Lenhard M. James, Reeves Grafton D., Continuous Subcutaneous Insulin Infusion : A Comprehensive Review of Insulin Pump Therapy, 10.1001/archinte.161.19.2293
  11. Tamborlane William V., Sherwin Robert S., Genel Myron, Felig Philip, Reduction to Normal of Plasma Glucose in Juvenile Diabetes by Subcutaneous Administration of Insulin with a Portable Infusion Pump, 10.1056/nejm197903153001101
  12. Herman W. H., Ilag L. L., Johnson S. L., Martin C. L., Sinding J., Al Harthi A., Plunkett C. D., LaPorte F. B., Burke R., Brown M. B., Halter J. B., Raskin P., A Clinical Trial of Continuous Subcutaneous Insulin Infusion Versus Multiple Daily Injections in Older Adults With Type 2 Diabetes, 10.2337/diacare.28.7.1568
  13. Hirsch Irl B., Brownlee Michael, Should minimal blood glucose variability become the gold standard of glycemic control?, 10.1016/j.jdiacomp.2004.10.001
  14. School Nurse News, 24, 12 (2007)
  15. Pediatrics, 1, 559 (2003)
  16. DeVries J. H., Snoek F. J., Kostense P. J., Masurel N., Heine R. J., A Randomized Trial of Continuous Subcutaneous Insulin Infusion and Intensive Injection Therapy in Type 1 Diabetes for Patients With Long-Standing Poor Glycemic Control, 10.2337/diacare.25.11.2074
  17. Education for Continuous Subcutaneous Insulin Infusion Pump Users, 10.1177/014572170302900113
  18. Carroll Mary F., Schade David S., THE DAWN PHENOMENON REVISITED: IMPLICATIONS FOR DIABETES THERAPY, 10.4158/ep.11.1.55
  19. Diabetes Care, S110 (2004)
  20. Keith Katherine, Nicholson David, Rogers Douglas, Accuracy and Precision of Low-Dose Insulin Administration Using Syringes, Pen Injectors, and a Pump, 10.1177/000992280404300109
  21. Diabetes Care, 2, S140 (2008)
  22. Diabetologia, 42, A235 (1999)
  23. J Pediatr Endocrinol Metab, 15, 607 (2002)
  24. Diabetes Metab, 27, 62 (2001)
  25. Jolanki Riitta, Kanerva Lasse, Estlander Tuula, Henriks-Eckerman Maj-Len, Suhonen Raimo, Allergic contact dermatitis from phenoxyethoxy ethylacrylates in optical fiber coating, and glue in an insulin pump set, 10.1034/j.1600-0536.2001.045001036.x
  26. Penn State Insulin Pump Therapy. http://www.hmc.psu.edu/healthinfo/i/insulinpumps.htm. Accessed October 18, 2008.
  27. American Diabetes Association. Insulin pumps. http://www.diabetes.org/type-1-diabetes/insulin-pumps.jsp. Accessed October 9, 2008.
  28. Pickup J., Keen H., Continuous Subcutaneous Insulin Infusion at 25 Years: Evidence base for the expanding use of insulin pump therapy in type 1 diabetes, 10.2337/diacare.25.3.593
  29. Prilozi, 28, 129 (2007)
  30. Ritholz M. D., Smaldone A., Lee J., Castillo A., Wolpert H., Weinger K., Perceptions of Psychosocial Factors and the Insulin Pump, 10.2337/dc06-1755
  31. Sherr Jennifer, Tamborlane William V., Past, present, and future of insulin pump therapy: better shot at diabetes control, 10.1002/msj.20055
  32. Hanas R., Brink S., Hitchcock J. Insulin pumps. In: Type 1 Diabetes: A Guide for Children, Adolescents, Young Adults-and Their Caregivers. Emeryville, CA: Marlowe & Company; 2005 :160-187.
  33. Fox L. A., Buckloh L. M., Smith S. D., Wysocki T., Mauras N., A Randomized Controlled Trial of Insulin Pump Therapy in Young Children With Type 1 Diabetes, 10.2337/diacare.28.6.1277
  34. Pediatr Endocrinol Rev, 2, 378 (2005)
  35. Phillip M., Battelino T., Rodriguez H., Danne T., Kaufman F., , Use of Insulin Pump Therapy in the Pediatric Age-Group: Consensus statement from the European Society for Paediatric Endocrinology, the Lawson Wilkins Pediatric Endocrine Society, and the International Society for Pediatric and Adolescent Diabetes, endorsed by the American Diabetes Association and the European Association for the Study of Diabetes, 10.2337/dc07-9922
  36. Eugster E. A., Francis G., , Position Statement: Continuous Subcutaneous Insulin Infusion in Very Young Children With Type 1 Diabetes, 10.1542/peds.2006-0662
  37. Weinzimer S. A., Ahern J. H., Doyle E. A., Vincent M. R., Dziura J., Steffen A. T., Tamborlane W. V., Persistence of Benefits of Continuous Subcutaneous Insulin Infusion in Very Young Children With Type 1 Diabetes: A Follow-up Report, 10.1542/peds.2004-0092
  38. Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial, 10.1016/s0022-3476(94)70190-3
  39. Cope J. U., Morrison A. E., Samuels-Reid J., Adolescent Use of Insulin and Patient-Controlled Analgesia Pump Technology: A 10-Year Food and Drug Administration Retrospective Study of Adverse Events, 10.1542/peds.2007-1707
  40. J Am Geriatr Soc., 51, S265 (2003)
  41. Diabetes Care, 29, S4 (2006)
  42. Diabetes Spectrum, 7, 80 (1994)
  43. Choosing and using an insulin pump infusion set (2008)
  44. Unger J. A primary care approach to continuous subcutaneous insulin infusion . Clin Diabetes. 1999;17(3). http://journal.diabetes.org/clinicaldiabetes/V17N31999/Pg113.htm . Accessed October 27, 2008.
  45. Diabetologia, 24, 326 (1983)
  46. Scheiner Gary, Boyer Bret A., Characteristics of basal insulin requirements by age and gender in Type-1 diabetes patients using insulin pump therapy, 10.1016/j.diabres.2004.11.005
  47. Exp Clin Endocrinol Diabetes, 116, 118 (2008)
  48. Skyler JS: Continous subcutaneous insulin infusion (CSII) with external devices: current status. In: Ensminger WD, Selam JL, eds. Update in Drug Delivery Systems. Mount Kisco, NY: Futura; 1989:163-183.
  49. Boland E. A., Grey M., Oesterle A., Fredrickson L., Tamborlane W. V., Continuous subcutaneous insulin infusion. A new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes, 10.2337/diacare.22.11.1779
  50. Bode B. W., Steed R. D., Davidson P. C., Reduction in Severe Hypoglycemia With Long-Term Continuous Subcutaneous Insulin Infusion in Type I Diabetes, 10.2337/diacare.19.4.324
  51. Samann A., Muhlhauser I., Bender R., Hunger-Dathe W., Kloos C., Muller U. A., Flexible Intensive Insulin Therapy in Adults With Type 1 Diabetes and High Risk for Severe Hypoglycemia and Diabetic Ketoacidosis, 10.2337/dc06-0751
  52. Think Like a Pancreas: A Practical Guide to Managing Diabetes With Insulin (2004)
  53. Wentholt I.M.E., Hart A.A.M., Hoekstra J.B.L., DeVries J.H., How to Assess and Compare the Accuracy of Continuous Glucose Monitors?, 10.1089/dia.2007.0216
  54. Garg S., Zisser H., Schwartz S., Bailey T., Kaplan R., Ellis S., Jovanovic L., Improvement in Glycemic Excursions With a Transcutaneous, Real-Time Continuous Glucose Sensor: A randomized controlled trial, 10.2337/diacare.29.01.06.dc05-1686
  55. 44th EASD Annual Meeting